Schedule 13G ownership disclosure
RAPT THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 75382E109
Event date: 2025-09-30
- Filing-level shares
- 1,086,618.00
- Percent of class
- 6.6%
- ORBIMED ADVISORS LLC
Shares: 1,086,618.00 · Class: 6.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-25-001022
- Form type
- SCHEDULE 13G/A
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership